Pediatric Hemispheric High-Grade Gliomas and H3.3-G34 Mutation: A Review of the Literature on Biological Features and New Therapeutic Strategies.
glioma
high-grade
histone mutation
immunotherapy
pediatric
targeted therapy
Journal
Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097
Informations de publication
Date de publication:
06 Aug 2024
06 Aug 2024
Historique:
received:
20
06
2024
revised:
25
07
2024
accepted:
02
08
2024
medline:
1
9
2024
pubmed:
31
8
2024
entrez:
29
8
2024
Statut:
epublish
Résumé
Pediatric high-grade glioma (pHGG) encompasses a wide range of gliomas with different genomic, epigenomic, and transcriptomic features. Almost 50% of pHGGs present a mutation in genes coding for histone 3, including the subtype harboring the H3.3-G34 mutation. In this context, histone mutations are frequently associated with mutations in
Identifiants
pubmed: 39202398
pii: genes15081038
doi: 10.3390/genes15081038
pii:
doi:
Substances chimiques
Histones
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM